Analyse produit facultative
Avec votre autorisation, nous utilisons une analyse limitée et respectueuse de la vie privée pour comprendre les parcours de recherche utiles. Nous n’utilisons ni traceurs publicitaires ni enregistrement de session. Vous pouvez modifier ce choix dans les préférences. Consultez la Politique de confidentialité.
Healthpeak Properties, Inc.'s published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $14.4B | |
|---|---|---|
| Revenue (ttm) | 2.9B | |
| Net income (ttm) | 242.7M | |
| EPS (ttm) | $0.34 | |
| Shares out | 702.5M | |
| P/E (trailing) | 53.8x | |
| P/E (forward) | 169.5x | |
| Dividend | $1.22 (6.61%) | |
| Volume | 3,305,847 | |
| Beta | 0.99 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $471.3M | $494.9M | $527.4M | $568.5M | $604.0M | +6.4% |
| Gross profit | $1.12B | $1.20B | $1.28B | $1.63B | $634.5M | -13.3% |
| Operating income | $286.3M | $680.1M | $515.3M | $553.6M | $415.5M | +9.8% |
| Net income | $505.5M | $500.4M | $306.0M | $243.1M | $71.3M | -38.7% |
| EPS (diluted) | $0.93 | $0.92 | $0.56 | $0.36 | $0.10 | -42.7% |
| EBITDA | $970.6M | $1.39B | $1.27B | $1.61B | $1.47B | +11.0% |
| R&D | $0 | $0 | $0 | — | — | +41.4% |
| SG&A | $98.3M | $131.0M | $95.1M | $97.2M | $90.4M | -2.1% |
Recent company headlines from major financial publishers.
Defensive outpatient medical cash flows deliver steady collections, balancing lab leasing drag and debt service to yield $29.98 from $20.33.
Post-merger integration accelerates synergies, outpatient rent escalations exceed historical norms, and life science leasing spreads rebound, supporting $40.86.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.4% | $78.0 | $78.3 | $78.8 | $79.4 | $80.2 |
| 7.4% | $42.6 | $42.8 | $43.1 | $43.5 | $43.9 |
| 8.4% | $29.6 | $29.8 | $30.0 | $30.2 | $30.5 |
| 9.4% | $22.8 | $23.0 | $23.1 | $23.3 | $23.4 |
| 10.4% | $18.6 | $18.7 | $18.8 | $18.9 | $19.1 |
Upcoming earnings date and setup when available.
La notation portée par l'édition de recherche publiée chaque mois. Une notation compare le cours à la date d'analyse à la juste valeur ; elle n'indique pas si l'appréciation s'est révélée juste.
| Année | janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
